BMO Capital Markets reiterated its Outperform rating on Eli Lilly and Company (NYSE:LLY), setting a price target of $900 ...

RiverPark Advisors, an investment advisory firm and sponsor of the RiverPark family of mutual funds, released its “RiverPark ...

A significant trading signal occurred for Eli Lilly stock, as it demonstrated a power inflow at $734.98, after which LLY rose ...

This was the stock's second consecutive day of gains.

Eli Lilly has morphed from a reliable pharma giant into a biotech powerhouse riding blockbuster success. Mounjaro and ...

Eli Lilly and Company is a global pharmaceutical company headquartered ... The result was an organization that was empowered, transparent and flexible. Teams were able to come up with better solutions ...

WestEnd Advisors LLC grew its position in Eli Lilly and Company by 210.0% in the first quarter. WestEnd Advisors LLC now owns 31 shares of the company’s stock valued at $26,000 after purchasing ...

We came across a bullish thesis on Eli Lilly and Company (LLY) on Substack by Kontra. In this article, we will summarize the bulls’ thesis on LLY. Eli Lilly and Company (LLY)’s share was ...

Thank you for joining us for Eli Lilly & Company's Q1 2025 earnings call ... basically to have a more transparent, closer pricing between list and net. Maybe important to say that based on ...

We're not interested in exclusive deals," Ricks said. A syringe and pills are in front of the logo of Eli Lilly pharmaceutical company. (Nikos Pekiaridis/NurPhoto via Getty Images) · NurPhoto via ...

In other Eli Lilly and Company news, CAO Donald A. Zakrowski sold 1,000 shares of the firm’s stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $818.24 ...